Article Review: Toll-like Receptors and COVID-19

Abstract

By March 2020, a pandemic had been emerged Corona Virus Infection in 2019 (COVID-19), which was triggered through the sensitive pulmonary syndrome (SARS disease corona virus- 2 (SARS COV-2). Overall precise path physiology of SARS COV-2 still unknown, as does the involvement of every element of the acute or adaptable immunity systems. Additionally, evidence from additional corona virus groups, including SARS COV as well as the Middle East pulmonary disease, besides that, fresh discoveries might help researchers fully comprehend SARS CoV-2. Toll-like receptors (TLRs) serve a critical part in both detection of viral particles as well as the stimulation of the body's immune response. When TLR systems are activated, pro-inflammatory cytokines like interleukin 1 (IL1), IL6, or nuclear factors, in addition to helpful interferon, are secreted. TLRs such as TLR2, TLR3, TLR4, TLR6, TLR7, TLR8, or TLR9 might possibly have a role in COVID-19 infections. It's also important noting that while dealing with COVID-19 infections, researchers should consider both the good or detrimental impacts of TLR. TLRs might be a focus for reducing infections inside the initial phases of the illness or developing a SARS CoV-2 vaccine.